Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 9 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-13 ORBIMED ADVISORS LLC 10% owner Sale −7,822 $8.98 $70K 5,500,730
2018-02-13 ORBIMED ADVISORS LLC 10% owner Sale −75 $8.98 $674 49,270
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise · Stock Option (right to buy) −6,057 0
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise · Stock Option (right to buy) −58 0
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise · Stock Option (right to buy) −1,765 0
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise · Stock Option (right to buy) −17 0
2018-01-25 KIRITSY CHRISTOPHER P Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-01-25 ADAMS JULIAN Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-01-25 BIZZARI JEAN-PIERRE Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-01-25 Richman Michael Director Grant or award · Stock Option (right to buy) +2,243 $5.09 $11K 2,243
2018-01-25 Richman Michael Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-01-25 Prelack Steven Director Grant or award · Stock Option (right to buy) +20,000 20,000
2018-01-25 GERAGHTY JAMES A Director Grant or award · Stock Option (right to buy) +25,000 25,000
2018-01-03 ORBIMED ADVISORS LLC 10% owner Sale −1,693,492 $7.35 $12.4M 5,500,730
2018-01-03 ORBIMED ADVISORS LLC 10% owner Sale −16,128 $7.35 $119K 49,270
2017-12-18 ORBIMED ADVISORS LLC 10% owner Option exercise +27,241 $2.00 $54K 7,221,463
2017-12-18 ORBIMED ADVISORS LLC 10% owner Option exercise +259 $2.00 $518 65,657
2017-12-18 ORBIMED ADVISORS LLC 10% owner Option exercise +5,227 $3.00 $16K 7,226,690
2017-12-18 ORBIMED ADVISORS LLC 10% owner Option exercise +50 $3.00 $150 65,707
2017-12-18 ORBIMED ADVISORS LLC 10% owner Option exercise +6,654 $2.62 $17K 7,233,344

Page 16 of 21 · 412 trades